Advertisement

Picture BIO Deutschland German Corona Special 2021 Digital 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 3067 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 22 23 24 ... 29 30 31  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Medicxi Ventures–EU (govt): investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–Novartis: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–SEVERAL: investment, 201706 closing $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
TissUse–Minapharm: organ-on-a-chip technology, 201706– license for HuALN platform for Multi-Organ-Chip applications from ProBioGen 2017-06-15
Bayer–China (govt): wheat breeding, 201706– collab 2y with SIBS + SIPPE to improve wheat yields via improved photosynthetic efficiency 2017-06-14
Pfizer–Basilea: isavuconazole, 201706– license CHF70m upfront + $427m milestones + royalties for prod + sales in Europe + RU + TR + IL 2017-06-14
Selexis–JSR Corp: investment, 201706 acquisition €na of Selexis SA by JSR Life Sciences 2017-06-14
Centogene–Careventures: investment, 201706 financing round Series A totalling €25m incl co-investor Careventures 2017-06-13
Centogene–Crédit Mutuel-CIC: investment, 201706 financing round Series A totalling €25m incl co-investor CIC Capital 2017-06-13
Centogene–DPE Deutsche Private Equity: investment, 201706 financing round Series A totalling €25m incl co-investor DPE 2017-06-13
Centogene–SEVERAL: investment, 201706 financing round Series A €25m led by TVM Capital + incl DPE + Careventures + CIC Capital 2017-06-13
Centogene–TVM: investment, 201706 financing round Series A totalling €25m incl lead investor TVM Capital Life Science 2017-06-13
CureVac–TiberendStrategic Advisors: public relations, 201706 service existent by Tiberend 2017-06-13
Kaken Pharmaceutical–Numab: therapeutic antibody, 201706– collab + license option €na for multispecific antibody for inflammatory disease 2017-06-13
4SC–SEVERAL: investment, 201706–201707 cash capital increase €41m with 11.68m new shares at €3.5/share 2017-06-12
Teneobio–Selexis: cell line development, 201706– supply service access to SUREtechnology platform to develop cell expression of UniAbs 2017-06-12
Lilly–Nordic Bioscience: antidiabetic, 201706– strategic collab $55m upfront + milestones + royalties ww rights to develop DACRAs from KeyBioscience 2017-06-08
Grünenthal–AstraZeneca: zolmitriptan, 201706 acquisition ww rights excl JP to Zomig $200m upfront + $102m milestones by Grünenthal 2017-06-07
Omeicos–Germany (govt): grant, 201706– additional BMBF research grant €1.7m 2017-06-07
CRISPR Therapeutics–Orgenesis: CAR-T cell therapies, 201706– supply CDMO services for allogenic CAR-T therapy CTX101 by MaSTherCell SA 2017-06-06
Thermo Fisher–Biocrates: AbsoluteIDQ Kits, 201706– collab co-marketing of new AbsoluteIDQ p400 HR Kit with Q Exactive HRAM MS systems 2017-06-05
Thermo Fisher–Biognosys: mass spectrometry s/w, 201706– collab co-marketing of Spectronaut Pulsar s/w with Orbitrap mass spectrometers 2017-06-05
Univ Maastricht–Bruker: mass spectrometry software, 201706 supply existent use of SCilS Lab s/w by M4I 2017-06-05
Merck (DE)–F-Star: antibody cancer drug, 201706– strategic collab €115m upfront + €1b milestones develop 5 bispecific ABs incl lead asset FS118 2017-06-04
BMS–Qiagen: molecular companion diagnostics, 201706– collab using NGS to develop gene expression profiles for cancer immunotherapies 2017-06-03
Qiagen–Johns Hopkins Univ: cancer biomarker, 201705– license ww to genetic biomarkers for use in I-O patient selection 2017-06-03
GATC Biotech–Eurofins: investment, 201706–201707 acquisition €na of GATC Biotech AG by Eurofins Scientific SE 2017-06-02
Bicycle Therapeutics–SEVERAL: investment, 201706 financing round Series B £40m led by new investor Vertex Ventures HC 2017-06-01
Indivumed–LADR/Intermed: investment, 201706 investment by Intermed as part of strategic alliance 2017-06-01
Waters–Andrew Alliance: automated liquid handling technology, 201706– collab co-marketing semi-automated sample prep solution 2017-06-01
Inthera Bioscience–SEVERAL: investment, 201705 financing round Series A CHF10.5m Merck Ventures + Aglaia BioMedical + Novo Seeds + private investor 2017-05-31
Strekin–SEVERAL: investment, 201705 financing round Series C CHF10m from private investors 2017-05-31
High-Tech Gründerfonds–SEVERAL: investment, 201705 first closing €245m of High-Tech Gründerfonds III (HTGF III) 2017-05-30
Taconic–ERS Genomics: CRISPR technology, 201705– license ww non-excl for CRISPR-Cas9 technology to generate murine models 2017-05-30
ViraTherapeutics–MC Services: public relations, 201705 service existent by MC Services 2017-05-30
Wise (IT)–SEVERAL: investment, 201705 financing round Series B €6.5m led by Principia SGR + incl Atlante Ventures + HTGF + F3F + Antares 2017-05-25
Debiopharm–ImmunoGen: antibody-drug conjugate, 201704 acquisition $25m upfront + $30m milestones of anti-CD37 ADC IMGN529 by Debiopharm 2017-05-24
Sartorius–SEVERAL: credit, 201705– note loan €350m with maturity terms of 5, 7 + 10 years arranged by Commerzbank + LBBW 2017-05-24
OSE Immunotherapeutics–Selexis: cell line development, 201705– commercial license for access to RCBs from SUREtechnology platform 2017-05-23
Signatope–High-Tech Gründerfonds: investment, 201705 investment €600k by HTGF 2017-05-23
TolerogenixX–High-Tech Gründerfonds: investment, 201705 seed financing from HTGF 2017-05-23
Clariant–Huntsman: investment, 201705–201710 merger of equals NOT REALISED 2017-05-21
Boehringer–Anagenesis: drug discovery technology, 201705– excl license to P2MC technology for drug developm for chronic muscle diseases 2017-05-18
Boehringer–Peking Univ: pharma r+d, 201705– collab strategic alliance incl therapeutics + regenerative medicine + gene therapy 2017-05-16
Exosomics Siena–Lonza: investment, 201705 strategic investment by Lonza 2017-05-16
HansaBioMed Life Sciences–Lonza: investment, 201705 acquisition of HBM-LS by Lonza 2017-05-16
Vesalius Biocapital–SEVERAL: investment, 201705 first closing €65m of Vesalius Biocapital III fund 2017-05-15
Cardior Pharmaceuticals–SEVERAL: investment, 201705 financing round Series A €15m led by LSP + BIVF + BMS + BioMedPartners + HTGF 2017-05-11
Numaferm–EU (govt): investment, 201705 seed financing round totalling €7-digit incl European Investment Fund 2017-05-11
Numaferm–High-Tech Gründerfonds: investment, 201705 seed financing round totalling €7-digit incl HTGF 2017-05-11
Numaferm–PERSON: investment, 201705 seed financing round totalling €7-digit incl business angels + Qiagen founders Detlev Riesner + Jürgen Schumacher 2017-05-11
Numaferm–SEVERAL: investment, 201705 seed financing round €7-digit from HTGF + Detlev Riesner + Jürgen Schumacher + EIF 2017-05-11
BC Platforms–Debiopharm: investment, 201705 financing round Series B totalling $10m co-led by Debiopharm Innovation Fund + Tesi 2017-05-09
BC Platforms–SEVERAL: investment, 201705 financing round Series B $10m co-led by Debiopharm Innovation Fund + Tesi 2017-05-09
BC Platforms–Tesi (FI): investment, 201705 financing round Series B totalling $10m co-led by Debiopharm Innovation Fund + Tesi 2017-05-09
Grzybowski Scientific Inventions–Merck (DE): investment, 201705 acquisition of GSI by Merck 2017-05-09
Aadi Bioscience–Helsinn: investment, 201705 financing round Series A totalling $23m incl $2m from co-investor Helsinn Investment Fund 2017-05-08
Aadi Bioscience–SEVERAL: investment, 201705 financing round Series A $23m led by Hermed Capital with Celgene + Vivo Capital + Helsinn et al 2017-05-08
CRISPR Therapeutics–MIT: lipid nanoparticle technolgy, 201705– excl license for family of LNP technologies for in vivo gene editing applications 2017-05-08
Genetrix (ES)–SEVERAL: investment, 201705– capital increase up to €10m w rights offering + private placement Sygnis AG 2017-05-08
Innova Biosciences–Genetrix (ES): investment, 201705–201707 acquisition €8m cash + 2m Sygnis shares plus up to 1.5m shares by Sygnis AG 2017-05-08
Luxendo–Bruker: investment, 201705 acquisition €na of Luxendo GmbH by Bruker 2017-05-08
Medigene–SEVERAL: investment, 201705 private placement €20.7m 1.965m new shares at €10.55/share to institutional investors 2017-05-04
MVZ für Laboratoriumsmedizin am Hygiene-Institut–Eurofins: investment, 201705– acquisition of Hygel by Eurofins ANNOUNCED 2017-05-04
Vivet Therapeutics–Columbus Venture Partners: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor CVP 2017-05-04
Vivet Therapeutics–Kurma: investment, 201705 financing round Series A totalling €37.5m incl co-investor Kurma Partners 2017-05-04
Vivet Therapeutics–Novartis: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor Novartis Venture Fund 2017-05-04
Vivet Therapeutics–Odlander Fredrikson: investment, 201705 financing round Series A totalling €37.5m incl co-investor HealthCap 2017-05-04
Vivet Therapeutics–Roche: investment, 201705 financing round Series A totalling €37.5m incl co-investor Roche Venture Fund 2017-05-04
Vivet Therapeutics–SEVERAL: investment, 201705 financing round Series A €37.5m led by Novartis Venture Fund + Columbus Venture Partners 2017-05-04
Vivet Therapeutics–Ysios Capital: investment, 201705 financing round Series A totalling €37.5m incl co-investor Ysios Capital 2017-05-04
AstraZeneca–Pieris: anticalin technology, 201705– collab developm + commerc $57.5m upfront + near-term inhaled respiratory drugs incl PRS-060 2017-05-03
PharmaCell–Lonza: investment, 201704 acquisition of PharmaCell BV by Lonza 2017-05-03
ImCheck Therapeutics–Boehringer: investment, 201705 financing round Series A totalling €20m incl co-lead investor BIVF 2017-05-02
ImCheck Therapeutics–Gimv: investment, 201705 financing round Series A totalling €20m incl co-investor Gimv 2017-05-02
ImCheck Therapeutics–Idinvest Partners: investment, 201705 financing round Series A totalling €20m incl co-lead investor Idinvest 2017-05-02
ImCheck Therapeutics–Kurma: investment, 201705 financing round Series A totalling €20m incl co-lead investor Kurma Partners 2017-05-02
ImCheck Therapeutics–Life Sciences Partners: investment, 201705 financing round Series A totalling €20m incl co-investor LSP 2017-05-02
ImCheck Therapeutics–SEVERAL: investment, 201705 financing round Series A €20m from BIVF + Kurma Partners + Idinvest + Gimv + LSP 2017-05-02
Magenta Therapeutics–Novartis: cell therapy product, 201705– license to MGTA-456 (HSC835) to expand cord blood stem cells for transplants 2017-05-02
Magenta Therapeutics–SEVERAL: investment, 201705 financing round Series B $50m led by GV + incl Atlas Venture + Third Rock Ventures et al 2017-05-02
Noxxon–SEVERAL: investment, 201705 private placement €1m capital increase incl €250k fron YA II PN Ltd 2017-05-02
Noxxon–Yorkville: credit, 201705–201811 convertible bonds up to €10m to YA II PN Ltd TERMINATED 11/18 2017-05-02
Caladrius–Hitachi: investment, 201705 acquisition of PCT LLC by Hitachi Chemical 2017-05-01
Aduro Biotech–Univ Bonn: cancer immunotherapy, 201704– license for STING agonists via Provendis to Aduro Biotech 2017-04-27
Arsanis–SEVERAL: investment, 201704 financing round Series D $45.5m led by Gates Foundation + incl GV + Alexandria Venture Investments et al 2017-04-26
Epigenomics–SEVERAL: investment, 201704–201707 public cash takeover offer €7.52/share FAILED valuing ECX at €171m incl net cash by CFUC + Biochain 2017-04-26
Microsaic–SCPA GmbH: chromatography software, 201704– collab integration of 4000 MiD MS system with PrepCon 5 preparative data + control s/w 2017-04-26
EMBL–Enamine: chemical compound library, 201704– collab library synthesis + medical chemistry + biological services for cancer drug research 2017-04-25
Forge Therapeutics–Evotec: investment, 201704 financing round Series A totalling $15m incl co-investor Evotec AG 2017-04-25
Forge Therapeutics–SEVERAL: investment, 201704 financing round Series A $15m led by MagnaSci Ventures + incl Evotec + Alexandria Venture et al 2017-04-25
KSK Diagnostics–Hamburg (govt): investment, 201704 financing round with HTGF + Innovationsstarter Fonds Hamburg 2017-04-24
KSK Diagnostics–High-Tech Gründerfonds: investment, 201704 financing round with HTGF + Innovationsstarter Fonds Hamburg 2017-04-24
KSK Diagnostics–SEVERAL: investment, 201704 financing round with HTGF + Innovationsstarter Fonds Hamburg 2017-04-24
Merck (DE)–Fresenius: investment, 201704–201709 acquisition €156m upfront + €500m milestones + royalties of Merck biosimilars business in Vaud CH 2017-04-24
Wilex–SEVERAL: investment, 201704– capital increase €4.99m with rights issue to existing shareholders incl dievini Hopp 2017-04-24
BioInvent–Merck (DE): bioreactors, 201704 supply full line of Mobius single-use bioreators to BioInvent upstream facility in Lund 2017-04-20
Seracell Pharma–Vita 34: investment, 201704– conditional 100% acquisition of up to €14m ANNOUNCED 2017-04-20
Gustavus Adolphus College–Agilent: grant, 201704– Thought Leader Award to Dwight Stoll to for 2D-LC research 2017-04-19
Hookipa–Instinctif Partners: public relations, 201704 service existent by Instinctif Partners 2017-04-19
next pagenext page 1 2 3 ... 22 23 24 ... 29 30 31  next pagenext page



Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px

» top